Development of inner blood-retinal barrier cell lines from transgehic rats harboring temperature-sensitive SV40 large T-antigen gene
从携带温度敏感的SV40大T抗原基因的转基因大鼠中开发内血视网膜屏障细胞系
基本信息
- 批准号:12557226
- 负责人:
- 金额:$ 8.19万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Conditionally immortalized rat retinal pericyte cell line(TR-rPCT) and Mailer cell line(TR-MUL) were established from transgenic rats harboring the temperature-sensitive SV 40 large T-antigen gene(tsA58 Tg rat). TR-rPCT and TR-MUL cells have pericyte and Muller cell markers and functions in vivo. These cell lines can be applied in co-culture with previously established conditionally immortalized rat retinal capillary endothelial cell line TR-iBRB). The co-culture studies suggest that soluble factors from TR-rPCT cells suppress the activation of PKC-p44/42 MAPK signaling and the expression of cyclin D1,cdk4,and cdk6,inhibit endothelial cell growth. Using TR-iBRB cells and TR-MUL cells, L-cystine transporter, system xc-was expressed and functioned at the inner blood-retinal barrier and plays a role in supplying L-cystine as a precursor of an antioxidant to the retina. TR-iBRB cells and TR-MUL cells expressed xCT and 4F2hc mRNA and protein and xCT was induced under oxidative stress conditions following diethyl maleate treatment. Vitamin C acts as an antioxidant and/or free radical scavenger to detoxify free radicals in the retina. GLUT1 is expressed in TR-iBRB cells and TR-MUL cells and transports dehydroascorbic acid, oxidized form of vitamin C. These results suggest that GLUT1 at the inner blood-retinal barrier plays a role in supplying vitamin C to the retina. TR-iBRB cells express LAT1 and have transport functions of neutral amino aqids, suggesting that LAT1 is expressed at the inner blood-retinal barrier and plays a role in supplying neutral amino acids to the retina. These findings suggest newly developed conditionally immortalized cell lines are useful in vitro models to study the inner blood-retinal barrier transport functions.
用温敏性SV 40大T抗原转基因大鼠(tsA58TG大鼠)建立了条件永生化大鼠视网膜周细胞系(tr-rPCT)和Mailer细胞系(tr-MUL)。Tr-rPCT和tr-MUL细胞在体内具有周细胞和Muller细胞标志物和功能。这些细胞系可用于与先前建立的条件永生化大鼠视网膜毛细血管内皮细胞系(TR-iBRB)共培养。共培养研究表明,来自tr-rPCT细胞的可溶性因子抑制了PKC-p44/42 MAPK信号通路的激活,抑制了细胞周期蛋白D1、CDK4和CDK6的表达,从而抑制了内皮细胞的生长。利用tr-iBRB细胞和tr-MUL细胞,L-胱氨酸转运蛋白系统XC-在血-视网膜内屏障表达并发挥作用,并作为视网膜抗氧化剂的前体供应L-胱氨酸。经顺丁烯二酸二乙酯处理后,在氧化应激条件下,tr-iBRB细胞和tr-MUL细胞表达Xct和4F2hc mRNA和蛋白,Xct被诱导。维生素C起抗氧化剂和/或自由基清除剂的作用,以消除视网膜中的自由基。Glut1在tr-iBRB细胞和tr-MUL细胞中表达,并运输脱氢抗坏血酸,维生素C的氧化形式。这些结果表明,位于血-视网膜内屏障的GLUT1在向视网膜供应维生素C方面发挥了作用。RT-iBRB细胞表达LAT1,并具有中性氨基酸转运功能,提示LAT1表达于血-视网膜内屏障,起到为视网膜提供中性氨基酸的作用。这些发现表明,新开发的条件永生化细胞系是研究血-视网膜内屏障运输功能的有用的体外模型。
项目成果
期刊论文数量(110)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
L.Shen: "Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells"Biochem.Pharmacol.. 66. 1945-1952 (2003)
L.Shen:“重组精氨酸脱亚胺酶作为培养内皮细胞中诱导型 (iNOS) 和内皮型 (eNOS) 一氧化氮合成酶活性的差异调节剂”Biochem.Pharmacol.. 66. 1945-1952 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
V.H.L.Lee: "Retina, Third Edition"S.J.Ryan, Mosby. 2601 (2001)
V.H.L.Lee:“视网膜,第三版”S.J.Ryan,莫斯比。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Kitazawa: "Characterization of the amino acid transport of new immortalized choroid plexus epithelial cell lines : A novel in vitro system for investigating transport functions at the blood-cerebrospinal fluid barrier"Pharm. Res.. 18. 16-22 (2001)
T.Kitazawa:“新型永生化脉络丛上皮细胞系的氨基酸转运特征:一种用于研究血脑脊液屏障转运功能的新型体外系统”Pharm。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Terasaki, S.Ohtsuki, S.Hori, H.Takanaga, E.Nakashima, K.Hosoya: "New approaches to in vitro models of the blood-brain barrier drug transport"Drug Discov.Today. 8. 944-954 (2003)
T.Terasaki、S.Ohtsuki、S.Hori、H.Takanaga、E.Nakashima、K.Hosoya:“血脑屏障药物转运体外模型的新方法”Drug Discov.Today。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Hosoya, A.Minamizono, K.Katayama, T.Terasaki, M.Tomi: "Vitamin C transport in oxidized form across the rat blood-retinal barrier"Invest.Ophthalmol.Vis.Sci.. 45. (2004)
K.Hosoya、A.Minamizono、K.Katayama、T.Terasaki、M.Tomi:“氧化形式的维生素 C 通过大鼠血-视网膜屏障运输”Invest.Ophasemol.Vis.Sci.. 45. (2004)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOSOYA Ken-ichi其他文献
HOSOYA Ken-ichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOSOYA Ken-ichi', 18)}}的其他基金
Evaluation of Cx43 proteins for PGE2 release from retinal pigment epithelial cells for understanding the pathological role in age-related macular degeneration.
评估 Cx43 蛋白对视网膜色素上皮细胞 PGE2 释放的影响,以了解年龄相关性黄斑变性的病理作用。
- 批准号:
16K15157 - 财政年份:2016
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Molecular mechanisms of prostaglandin elimination across brain barriers and its application to neural inflammatory diseases
前列腺素跨脑屏障消除的分子机制及其在神经炎症疾病中的应用
- 批准号:
24659072 - 财政年份:2012
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Molecular identification and physiological role of brain-type prostaglandin transporter
脑型前列腺素转运蛋白的分子鉴定及其生理作用
- 批准号:
21390042 - 财政年份:2009
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Antioxidants transport via GLUT1 at the blood-retinal barrier
抗氧化剂通过 GLUT1 在血视网膜屏障上转运
- 批准号:
15390046 - 财政年份:2003
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular analysis of cell growth regulating factor in retinal, capillary endothelial cells
视网膜、毛细血管内皮细胞细胞生长调节因子的分子分析
- 批准号:
12672206 - 财政年份:2000
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




